Sunday, June 15, 2025
20.8 C
Bengaluru

Healthcare Isn’t Working As Well As It Should – A Brief Summary Of The ZS Report 2024

The ZS report discusses how people feel about healthcare today and what can be done to improve it.

  1. Frustration with Costs: Many people find healthcare too expensive, leading to an inability to afford necessary care.
  2. Access Challenges:
    • Doctors are busy.
    • Scheduling appointments is difficult.
    • It often takes a long time to get seen.
  3. Impersonal Experience: Doctors may not have enough time to build a personal relationship with their patients.
  4. Patient Desires:
    • Affordable healthcare.
    • Easy access to services.
    • Quick appointments.
    • Convenient locations.
    • Options for online consultations.
    • More personalized care, where doctors listen to and understand patient needs.
  5. Proposed Solution: The ZS report suggests that technology, including computers and AI, can help resolve these issues.
  6. Potential Benefits of AI:
    • Assist doctors in making diagnoses more quickly and accurately.
    • Simplify the scheduling process and paperwork management.
    • Empower individuals to manage their health at home through apps and wearable devices.
  7. Challenge of Implementation:
    • Utilizing technology effectively is a complex challenge.
    • Requires collaboration between doctors, hospitals, insurance companies, and technology firms.
  8. Call for Change: The ZS report emphasizes improving healthcare through enhanced access, reduced costs, and a more patient-friendly experience, highlighting technology and collaboration as essential components for achieving these improvements.

A MedicinManAI Feature

About ZS

ZS is a management consulting and technology firm that partners with companies to improve life and
how we live it. We transform ideas into impact by combining data, science, technology, and human ingenuity to deliver better outcomes for all. Founded in 1983, ZS has more than 13,000 employees in more than 35 offices worldwide. To learn more, visit www.zs.com or follow us on LinkedIn.

Explore the 2025 ZS Future of Health Report on ZS.com. Learn more: zs.com/futureofhealth

Pharma professionals should follow @ZSAssociates on X to stay abreast of healthcare news, insights, and surveys.

Hot this week

Biologics Patent Cliff (2025–2029): A Golden Opportunity for Indian Pharma

https://www.pharmamanufacturing.com/articles/2011/095 A quiet but seismic shift is underway in global...

Zaynich and the $9 Billion Moment: A New Dawn for Indian Pharma?

A quiet but revolutionary milestone may be unfolding in...

AI and the Future of Pharma Field Sales: Boon or Bane?

India’s pharmaceutical industry runs on the strength of its...

Semaglutide – More Than Just a Patent Battle

The Delhi High Court has restrained Dr. Reddy’s and...

Novo Nordisk — Septerna’s $2.2 Billion Deal

A New Era for Obesity Pills Novo Nordisk has announced...

Topics

Biologics Patent Cliff (2025–2029): A Golden Opportunity for Indian Pharma

https://www.pharmamanufacturing.com/articles/2011/095 A quiet but seismic shift is underway in global...

Zaynich and the $9 Billion Moment: A New Dawn for Indian Pharma?

A quiet but revolutionary milestone may be unfolding in...

AI and the Future of Pharma Field Sales: Boon or Bane?

India’s pharmaceutical industry runs on the strength of its...

Semaglutide – More Than Just a Patent Battle

The Delhi High Court has restrained Dr. Reddy’s and...

Novo Nordisk — Septerna’s $2.2 Billion Deal

A New Era for Obesity Pills Novo Nordisk has announced...

GSK Bets Big on Liver Disease: $1.2B Upfront for Boston Pharma’s MASH Drug

In a bold move to strengthen its hepatology pipeline,...

Indian Pharma Market Performance – April 2025

The Indian Pharmaceutical Market (IPM) maintained moderate growth in...
spot_img

Related Articles

spot_imgspot_img